BRULX
Price
$15.83
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
296.26M
VIVAX
Price
$67.64
Change
+$0.12 (+0.18%)
Updated
Jun 20 closing price
Net Assets
188.77B
Interact to see
Advertisement

BRULX vs VIVAX

Header iconBRULX vs VIVAX Comparison
Open Charts BRULX vs VIVAXBanner chart's image
MFS Blended Research Value Equity R3
Price$15.83
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets296.26M
Vanguard Value Index I
Price$67.64
Change+$0.12 (+0.18%)
VolumeN/A
Net Assets188.77B
BRULX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRULX vs. VIVAX commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRULX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. BRULX (296M). VIVAX pays higher dividends than BRULX: VIVAX (2.16) vs BRULX (1.41). BRULX was incepted earlier than VIVAX: BRULX (10 years) vs VIVAX (33 years). BRULX (0.85) is less costly to investors than VIVAX (0.17). BRULX is a more actively managed with annual turnover of: 55.00 vs. VIVAX (9.00). BRULX has a lower initial minimum investment than VIVAX: BRULX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.93 vs. BRULX (-1.34). VIVAX return over 5 years is better than : 71.12 vs. BRULX (45.94).
BRULXVIVAXBRULX / VIVAX
Total Expense Ratio0.740.17435%
Annual Report Gross Expense Ratio0.850.17500%
Fund Existence10 years33 years-
Gain YTD4.2132.419174%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets296M189B0%
Annual Yield % from dividends1.412.1666%
Returns for 1 year-1.346.93-19%
Returns for 3 years21.0632.4665%
Returns for 5 years45.9471.1265%
Returns for 10 yearsN/A102.45-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKBA3.680.12
+3.37%
Akebia Therapeutics
ICLR146.482.90
+2.02%
ICON plc
BCAB0.40N/A
+0.73%
BioAtla
OPAD0.960.01
+0.71%
Offerpad Solutions
SKYW95.22-1.65
-1.70%
SkyWest